FDA — authorised 18 December 2019
- Application: NDA022247
- Marketing authorisation holder: WYETH PHARMS
- Indication: Labeling
- Status: approved
🇺🇸 Duavee in United States
FDA authorised Duavee on 18 December 2019
Marketing authorisation
Duavee in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Duavee approved in United States?
Yes. FDA authorised it on 18 December 2019.
Who is the marketing authorisation holder for Duavee in United States?
WYETH PHARMS holds the US marketing authorisation.